Five NRGs were identified to have a significant correlation with the prognosis of BLCA patients: CAMK2A, CHMP4C, IL33, IRF9, and TRAF5 (Supplementary Table S5; Figure 6). Here, IL33 is linked to bladder transitional cell carcinoma.